Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2003
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003066621A8 Piperidine derivatives and their use as antagonists of tachykinins
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003053331A3 Protease inhibitors
11/13/2003WO2003042113A8 Production of cell suspensions
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003030944A3 Inhibition of stat-1
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003017939A3 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002088137A9 Pkb-3564 substance with neovascularization inhibitory activity
11/13/2003WO2002066681A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
11/13/2003WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
11/13/2003WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors
11/13/2003WO2002040020A9 Novel use of certain insulin sensitizers or ppar-gamma agonists
11/13/2003US20030212273 Pyrrolo [2,3-D] pyrimidine compounds
11/13/2003US20030212249 Synthesis of cyclosporin analogs
11/13/2003US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212074 Phosphate transport inhibitors
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212065 Using a imidazolo(4,5,1-ij)quinoline compound
11/13/2003US20030212058 Side effect reduction; osteoporosis therapy
11/13/2003US20030212055 Cinnoline compounds
11/13/2003US20030212048 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003CA2703698A1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003CA2489009A1 Connective tissue stimulating peptides
11/13/2003CA2487693A1 Method for producing preparations rich in tocotrienol
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2484797A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484258A1 Soya cell strains with high isoflavone content
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2484024A1 Surgical material comprising water soluble glass fibres
11/13/2003CA2483904A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483084A1 Tyrosine kinase inhibitors
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/12/2003EP1360504A2 Method for screening compounds for activity in treating an osteoclast related bone disease
11/12/2003EP1360500A2 Methods for selective targeting
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1216057B1 Stable calcitriol solution for packaging in vials
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1094815B1 Farnesyl protein transferase inhibitors for treating arthropathies
11/12/2003EP0991618B1 Selective thyroid hormone analogs
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003CN2586281Y Intelligent series charger
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455672A Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength
11/12/2003CN1454660A Bone-setting medicine
11/12/2003CN1454659A Safflower oil
11/12/2003CN1454657A Bone-setting powdered medicine composition
11/12/2003CN1454655A Medicine for curing rheumatoid disease and chronic bronchitis and preparing method thereof
11/12/2003CN1454652A Medicinal liquor for curing traumatic injury and rheumatalgia and preparing method thereof
11/12/2003CN1454649A Exothermic therapeutic bag of Chinese herbal medicine and preparing method thereof
11/12/2003CN1454648A Medicinal liquor for curing rheumatism and traumatic injuries
11/12/2003CN1454646A Chinese medicine preparation for curing osteoporosis and preparing method thereof
11/12/2003CN1454645A External-use Chinese medicine preparation for wind-dispelling and dampness-removing and preparing method thereof
11/12/2003CN1454620A Osteoproliferation medicine and preparing method thereof
11/12/2003CN1127568C Fibroblast growth factor homologs
1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 820